In early stages of fibrillary tau formation in neurons, TG1, along with TG1 activator TIG3, catalyzes the crosslinking of tau proteins, leading to the formation of stable tau aggregates and increasing neurotoxicity and leading to neuronal death in these tauopathies [107]. The gene discussed is MAPT; the disease is tauopathy.